ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KSI Kneat Com Inc

4.21
0.00 (0.00%)
28 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Kneat Com Inc TSX:KSI Toronto Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.21 4.09 4.24 0 01:00:00

Kneat to Announce 2023 Fourth-Quarter and Fiscal Year Financial Results February 21, 2024

13/02/2024 10:12pm

GlobeNewswire Inc.


Kneat Com (TSX:KSI)
Historical Stock Chart


From Nov 2023 to May 2024

Click Here for more Kneat Com Charts.

kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial results for the year ended December 31, 2023, after TSX market close on February 21, 2024.

Eddie Ryan, Chief Executive Officer and Hugh Kavanagh, Chief Financial Officer, will host a conference call and Q&A for sell side analysts via webcast on February 22, 2024 at 09:00 ET (14:00 GMT).

Interested parties can register for the live webcast via the following link:

Register Here

The fourth-quarter and fiscal year financial results will be available from the Financial Information section of the Investors page on the Kneat Solutions website, at: https://kneat.com/investors/

About KneatKneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx software platform (“Kneat Gx”). Multiple business work processes can be configured on the platform, from equipment to computer system validation, through to quality document management. Kneat Gx allows users to author, review, approve, execute testing online, manage any exceptions and post-approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects, and processes globally. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit www.kneat.com.

For further information:

Katie Keita, Investor Relations Lead, +902-706-9074, katie.keita@kneat.com

1 Year Kneat Com Chart

1 Year Kneat Com Chart

1 Month Kneat Com Chart

1 Month Kneat Com Chart